ADVOCATE. CONNECT. INNOVATE.

Science & Medicine Group and CLSA present: COVID-19 Impact on Drug Discovery Life Science Labs and Companion Diagnostics

Online

5/27/2020

11:00am - 12:00pm

CLSA and Science and Medicine Group invite you to a live webinar to share insights on the impact of COVID-19 on drug discovery life science labs and companion diagnostics.

How is the current COVID-19 Crisis affecting labs across the country and in California? How are life science research labs and clinical labs navigating their challenges?
Based on weekly and bi-weekly tracking surveys since April 2020, over 1,000 global life science and diagnostics labs answer questions regarding the impact of COVID-19 on their operations.

Topics Covered:
• Lab Sentiment, Closure Time & Ramp Up Expectations
• Economic Impact & Change in Spending
• Shifts in Volume of COVID-19 and non-COVID-19 Tests in hospitals and non-hospital labs
• Support needed from vendors by Infectious Disease Research Labs
• Demographics

We are dedicated to bringing you the most important perspective of all — your customer's — into this highly dynamic global situation.

Based on weekly and bi-weekly trackers, US drug discovery life science and diagnostics labs answer questions regarding the impact of COVID-19 on their operations.

Topics Covered:
• Lab Closure Time & Ramp Up Expectations
• Lab Focus
• Economic Impact & Change in Spending
• Overall Worry
• Overall Impact
• Impact on Volume of Tests
• Support Needed by Infectious Disease Labs
• Demographics

What: Live Webinar on Impact of COVID-19 Clinical Dx Lab Tracker
When: May 27 at 11:00 AM PDT
Your Hosts: CLSA and Science and Medicine Group

We are dedicated to bringing you the most important perspective of all — your customer's — into this highly dynamic global situation.

Click Here for More Information

Contact: Justin Dudash
Contact Email: j.dudash@bioinfoinc.com